View in EDS HTML Full Text PDF Full Text

Safety and efficacy of filgotinib for Japanese patients with RA and inadequate response to MTX: FINCH 1 52-week results and FINCH 4 48-week results.

Saved in:
Bibliographic Details
Title: Safety and efficacy of filgotinib for Japanese patients with RA and inadequate response to MTX: FINCH 1 52-week results and FINCH 4 48-week results.
Authors: Tanaka Y; First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan., Matsubara T; Department of Orthopedics, Matsubara Mayflower Hospital, Kato, Hyogo, Japan., Atsumi T; Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan., Amano K; Department of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University, Hidaka, Saitama, Japan., Ishiguro N; Aichi Developmental Disability Center, Kasugai, Aichi, Japan., Sugiyama E; Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan., Yamaoka K; Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan., Combe BG; Rheumatology Department, CHU Montpellier, Montpellier University, Montpellier, France., Kivitz AJ; Altoona Center for Clinical Research, Duncansville, PA, USA., Bae SC; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Hanyang University Institute for Rheumatology Research and Hanyang University Institute of Bioscience and Biotechnology, Seoul, Korea., Keystone EC; Department of Medicine, University of Toronto, Toronto, ON, Canada., Nash P; Griffith University of Queensland, Brisbane, Queensland, Australia., Genovese M; Gilead Sciences Inc., Foster City, CA, USA., Matzkies F; Gilead Sciences Inc., Foster City, CA, USA., Bartok B; Gilead Sciences Inc., Foster City, CA, USA., Pechonkina A; Gilead Sciences Inc., Foster City, CA, USA., Kondo A; Gilead Sciences K.K., Tokyo, Japan., Ye L; Gilead Sciences Inc., Foster City, CA, USA., Gong Q; Gilead Sciences Inc., Foster City, CA, USA., Tasset C; Galapagos NV, Mechelen, Belgium., Takeuchi T; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan, and Saitama Medical University, Iruma, Saitama, Japan.
Source: Modern rheumatology [Mod Rheumatol] 2023 Jul 04; Vol. 33 (4), pp. 668-679.
Publication Type: Randomized Controlled Trial; Journal Article
Journal Info: Publisher: Oxford University Press Country of Publication: England NLM ID: 100959226 Publication Model: Print Cited Medium: Internet ISSN: 1439-7609 (Electronic) Linking ISSN: 14397595 NLM ISO Abbreviation: Mod Rheumatol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35920102
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Safety and efficacy of filgotinib for Japanese patients with RA and inadequate response to MTX: FINCH 1 52-week results and FINCH 4 48-week results.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Tanaka+Y%22">Tanaka Y</searchLink>; First Department of Internal Medicine, School of Medicine, University of Occupational and Environmental Health, Japan, Kitakyushu, Japan.<br /><searchLink fieldCode="AU" term="%22Matsubara+T%22">Matsubara T</searchLink>; Department of Orthopedics, Matsubara Mayflower Hospital, Kato, Hyogo, Japan.<br /><searchLink fieldCode="AU" term="%22Atsumi+T%22">Atsumi T</searchLink>; Department of Rheumatology, Endocrinology and Nephrology, Faculty of Medicine, Hokkaido University, Sapporo, Hokkaido, Japan.<br /><searchLink fieldCode="AU" term="%22Amano+K%22">Amano K</searchLink>; Department of Rheumatology and Clinical Immunology, Saitama Medical Center, Saitama Medical University, Hidaka, Saitama, Japan.<br /><searchLink fieldCode="AU" term="%22Ishiguro+N%22">Ishiguro N</searchLink>; Aichi Developmental Disability Center, Kasugai, Aichi, Japan.<br /><searchLink fieldCode="AU" term="%22Sugiyama+E%22">Sugiyama E</searchLink>; Department of Clinical Immunology and Rheumatology, Hiroshima University Hospital, Hiroshima, Japan.<br /><searchLink fieldCode="AU" term="%22Yamaoka+K%22">Yamaoka K</searchLink>; Department of Rheumatology and Infectious Diseases, Kitasato University School of Medicine, Sagamihara, Kanagawa, Japan.<br /><searchLink fieldCode="AU" term="%22Combe+BG%22">Combe BG</searchLink>; Rheumatology Department, CHU Montpellier, Montpellier University, Montpellier, France.<br /><searchLink fieldCode="AU" term="%22Kivitz+AJ%22">Kivitz AJ</searchLink>; Altoona Center for Clinical Research, Duncansville, PA, USA.<br /><searchLink fieldCode="AU" term="%22Bae+SC%22">Bae SC</searchLink>; Department of Rheumatology, Hanyang University Hospital for Rheumatic Diseases, Hanyang University Institute for Rheumatology Research and Hanyang University Institute of Bioscience and Biotechnology, Seoul, Korea.<br /><searchLink fieldCode="AU" term="%22Keystone+EC%22">Keystone EC</searchLink>; Department of Medicine, University of Toronto, Toronto, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Nash+P%22">Nash P</searchLink>; Griffith University of Queensland, Brisbane, Queensland, Australia.<br /><searchLink fieldCode="AU" term="%22Genovese+M%22">Genovese M</searchLink>; Gilead Sciences Inc., Foster City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Matzkies+F%22">Matzkies F</searchLink>; Gilead Sciences Inc., Foster City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Bartok+B%22">Bartok B</searchLink>; Gilead Sciences Inc., Foster City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Pechonkina+A%22">Pechonkina A</searchLink>; Gilead Sciences Inc., Foster City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Kondo+A%22">Kondo A</searchLink>; Gilead Sciences K.K., Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Ye+L%22">Ye L</searchLink>; Gilead Sciences Inc., Foster City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Gong+Q%22">Gong Q</searchLink>; Gilead Sciences Inc., Foster City, CA, USA.<br /><searchLink fieldCode="AU" term="%22Tasset+C%22">Tasset C</searchLink>; Galapagos NV, Mechelen, Belgium.<br /><searchLink fieldCode="AU" term="%22Takeuchi+T%22">Takeuchi T</searchLink>; Division of Rheumatology, Department of Internal Medicine, Keio University School of Medicine, Tokyo, Japan, and Saitama Medical University, Iruma, Saitama, Japan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22100959226%22">Modern rheumatology</searchLink> [Mod Rheumatol] 2023 Jul 04; Vol. 33 (4), pp. 668-679.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Randomized Controlled Trial; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Oxford+University+Press%22">Oxford University Press </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>100959226 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1439-7609 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2214397595%22">14397595 </searchLink><i>NLM ISO Abbreviation: </i>Mod Rheumatol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35920102
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1093/mr/roac084
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 668
    Titles:
      – TitleFull: Safety and efficacy of filgotinib for Japanese patients with RA and inadequate response to MTX: FINCH 1 52-week results and FINCH 4 48-week results.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Tanaka Y
      – PersonEntity:
          Name:
            NameFull: Matsubara T
      – PersonEntity:
          Name:
            NameFull: Atsumi T
      – PersonEntity:
          Name:
            NameFull: Amano K
      – PersonEntity:
          Name:
            NameFull: Ishiguro N
      – PersonEntity:
          Name:
            NameFull: Sugiyama E
      – PersonEntity:
          Name:
            NameFull: Yamaoka K
      – PersonEntity:
          Name:
            NameFull: Combe BG
      – PersonEntity:
          Name:
            NameFull: Kivitz AJ
      – PersonEntity:
          Name:
            NameFull: Bae SC
      – PersonEntity:
          Name:
            NameFull: Keystone EC
      – PersonEntity:
          Name:
            NameFull: Nash P
      – PersonEntity:
          Name:
            NameFull: Genovese M
      – PersonEntity:
          Name:
            NameFull: Matzkies F
      – PersonEntity:
          Name:
            NameFull: Bartok B
      – PersonEntity:
          Name:
            NameFull: Pechonkina A
      – PersonEntity:
          Name:
            NameFull: Kondo A
      – PersonEntity:
          Name:
            NameFull: Ye L
      – PersonEntity:
          Name:
            NameFull: Gong Q
      – PersonEntity:
          Name:
            NameFull: Tasset C
      – PersonEntity:
          Name:
            NameFull: Takeuchi T
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 04
              M: 07
              Text: 2023 Jul 04
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1439-7609
          Numbering:
            – Type: volume
              Value: 33
            – Type: issue
              Value: 4
          Titles:
            – TitleFull: Modern rheumatology
              Type: main
ResultId 1